September 4, 2007- New recommendations released today in the Journal of the American Society of Echocardiography further support the role of stress echo in accurately identifying coronary artery disease (CAD), determining prognosis of patients with known or suspected CAD, in addition to providing recommendations for optimizing imaging.

In addition, through advances in the use of stress echo, physicians can tell whether regions of non-contracting heart muscle are still alive, or viable and can determine if these regions are not contracting due to current lack of blood flow to the specific area, or are not contracting due to a prior history of lack of blood flow to the specified area.

The newly released guidelines are an evolution of the 1998 stress echo guidelines published by the American Society of Echocardiography (ASE). With access to more data and continued research, today’s guidelines include refinements in testing protocols, including recommendations on what information should be obtained during stress echo and standards for image interpretation and important progress towards quantitative analysis.

The new guidelines also include recommendations for optimizing imaging. According to the stress echo recommendations for performance, tissue harmonic imaging should be used for stress echocardiography. Tissue harmonic imaging improves the sensitivity of stress echo by reducing near field artifact, improving resolution and enhancing myocardial signals and is superior to fundamental imaging for endocardial border visualization.

Additionally, recommendations encourage physicians to utilize contrast agents during stress echo, in conjunction with harmonic tissue imaging, when two or more of the left ventricular wall segments cannot be clearly viewed. This pairing of contrast agents and harmonic imaging increases the number of visible left ventricular wall segments, improves the accuracy of stress echo readers, enhances diagnostic confidence and reduces the need for additional noninvasive tests.

For more information: www.asecho.org


Related Content

News | FDA

March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and ...

Time March 06, 2024
arrow
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
arrow
News | Interventional Radiology

January 10, 2024 — Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ...

Time January 10, 2024
arrow
News | Radiology Business

October 10, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...

Time October 10, 2023
arrow
News | Point-of-Care Ultrasound (POCUS)

October 6, 2023 — GE HealthCare announced its Venue Family point-of-care ultrasound systems will now feature Caption ...

Time October 06, 2023
arrow
News | Point-of-Care Ultrasound (POCUS)

October 4, 2023 — Butterfly Network, Inc. a digital health company transforming care through the power of portable ...

Time October 04, 2023
arrow
Feature | Ultrasound Imaging

February 10, 2023 — GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement ...

Time February 10, 2023
arrow
News | Ultrasound Imaging

February 14, 2022 – Clarius Mobile Health has introduced a third-generation product line of high-performance handheld ...

Time February 14, 2022
arrow
News | Artificial Intelligence

November 11, 2021 — Caption Health and Ultromics, developers of artificial intelligence (AI) to improve cardiac ...

Time November 11, 2021
arrow
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Time October 06, 2021
arrow
Subscribe Now